CLINICAL TRIALS PROFILE FOR JESDUVROQ
✉ Email this page to a colleague
All Clinical Trials for JESDUVROQ
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT05951192 ↗ | A Prospective Interventional Study Assessing the Clinical and Operational Effectiveness of Transitioning From Mircera to Daprodustat for the Treatment of Anemia in End Stage Kidney Disease | Completed | GlaxoSmithKline | Phase 4 | 2023-07-01 | Investigator-initiated, interventional, prospective study to assess the clinical and operational effectiveness of daprodustat in adult patients receiving in center hemodialysis or peritoneal home dialysis who are transitioning from Mircera to daprodustat. |
NCT05951192 ↗ | A Prospective Interventional Study Assessing the Clinical and Operational Effectiveness of Transitioning From Mircera to Daprodustat for the Treatment of Anemia in End Stage Kidney Disease | Completed | USRC Kidney Research | Phase 4 | 2023-07-01 | Investigator-initiated, interventional, prospective study to assess the clinical and operational effectiveness of daprodustat in adult patients receiving in center hemodialysis or peritoneal home dialysis who are transitioning from Mircera to daprodustat. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for JESDUVROQ
Condition Name
Clinical Trial Locations for JESDUVROQ
Trials by Country
Clinical Trial Progress for JESDUVROQ
Clinical Trial Phase
Clinical Trial Sponsors for JESDUVROQ
Sponsor Name